Viewing Study NCT06992258


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2025-12-25 @ 10:02 PM
Study NCT ID: NCT06992258
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-04-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Sponsor: Criterium, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module